ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Polypeptide Vaccine Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-34N17663
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Polypeptide Vaccine Market Research Report 2024
BUY CHAPTERS

Global Polypeptide Vaccine Market Research Report 2024

Code: QYRE-Auto-34N17663
Report
August 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AmbioPharm
ALMAC
ACT
Ultimovacs
Immatics
Anergis
SELLAS Life Sciences
Marker Therapeutics, Inc.
OncoPep

Polypeptide Vaccine Market

Polypeptide Vaccine is an anti-tumor therapeutic vaccine with the most researches, the best effect and the most mature technology among various therapeutic vaccines. Known as subunit vaccines, compared with traditional inactivated and attenuated vaccines, peptide vaccines can not only be used as preventive vaccines against infectious or non-infectious diseases, but also for the treatment of Alzheimer's disease, malignant tumors, etc.; peptide vaccines have become a new strategy for anti-tumor at present, and peptide anti-tumor therapeutic vaccines have accounted for the largest proportion of biotechnology anti-cancer new drugs under development.
The global Polypeptide Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Polypeptide Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Polypeptide Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Polypeptide Vaccine include AmbioPharm, Almac, ACT, Ultimovacs, Marker Therapeutics, Inc., Immatics, OncoPep, Anergis, Sellas Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polypeptide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polypeptide Vaccine.
The Polypeptide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Polypeptide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polypeptide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Polypeptide Vaccine Market Report

Report Metric Details
Report Name Polypeptide Vaccine Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AmbioPharm, Almac, ACT, Ultimovacs, Marker Therapeutics, Inc., Immatics, OncoPep, Anergis, Sellas Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Polypeptide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Polypeptide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Polypeptide Vaccine Market report?

Ans: The main players in the Polypeptide Vaccine Market are AmbioPharm, Almac, ACT, Ultimovacs, Marker Therapeutics, Inc., Immatics, OncoPep, Anergis, Sellas Life Sciences

What are the Application segmentation covered in the Polypeptide Vaccine Market report?

Ans: The Applications covered in the Polypeptide Vaccine Market report are Infectious Disease Prevention, Cancer Immunotherapy, Others

What are the Type segmentation covered in the Polypeptide Vaccine Market report?

Ans: The Types covered in the Polypeptide Vaccine Market report are Synthetic Polypeptide Vaccines, Recombinant Polypeptide Vaccine, Others

Recommended Reports

Cancer Immunotherapy Vaccines

Preventive Human Vaccines

Genetically Engineered Vaccines

1 Polypeptide Vaccine Market Overview
1.1 Product Definition
1.2 Polypeptide Vaccine by Type
1.2.1 Global Polypeptide Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Synthetic Polypeptide Vaccines
1.2.3 Recombinant Polypeptide Vaccine
1.2.4 Others
1.3 Polypeptide Vaccine by Application
1.3.1 Global Polypeptide Vaccine Market Value by Application (2024-2030)
1.3.2 Infectious Disease Prevention
1.3.3 Cancer Immunotherapy
1.3.4 Others
1.4 Global Polypeptide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Polypeptide Vaccine Revenue 2019-2030
1.4.2 Global Polypeptide Vaccine Sales 2019-2030
1.4.3 Global Polypeptide Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Polypeptide Vaccine Market Competition by Manufacturers
2.1 Global Polypeptide Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Polypeptide Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Polypeptide Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Polypeptide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polypeptide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polypeptide Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Polypeptide Vaccine, Date of Enter into This Industry
2.8 Global Polypeptide Vaccine Market Competitive Situation and Trends
2.8.1 Global Polypeptide Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Polypeptide Vaccine Players Market Share by Revenue
2.8.3 Global Polypeptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polypeptide Vaccine Market Scenario by Region
3.1 Global Polypeptide Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Polypeptide Vaccine Sales by Region: 2019-2030
3.2.1 Global Polypeptide Vaccine Sales by Region: 2019-2024
3.2.2 Global Polypeptide Vaccine Sales by Region: 2025-2030
3.3 Global Polypeptide Vaccine Revenue by Region: 2019-2030
3.3.1 Global Polypeptide Vaccine Revenue by Region: 2019-2024
3.3.2 Global Polypeptide Vaccine Revenue by Region: 2025-2030
3.4 North America Polypeptide Vaccine Market Facts & Figures by Country
3.4.1 North America Polypeptide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Polypeptide Vaccine Sales by Country (2019-2030)
3.4.3 North America Polypeptide Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polypeptide Vaccine Market Facts & Figures by Country
3.5.1 Europe Polypeptide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Polypeptide Vaccine Sales by Country (2019-2030)
3.5.3 Europe Polypeptide Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polypeptide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Polypeptide Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Polypeptide Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Polypeptide Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Polypeptide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Polypeptide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Polypeptide Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Polypeptide Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Polypeptide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Polypeptide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Polypeptide Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Polypeptide Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polypeptide Vaccine Sales by Type (2019-2030)
4.1.1 Global Polypeptide Vaccine Sales by Type (2019-2024)
4.1.2 Global Polypeptide Vaccine Sales by Type (2025-2030)
4.1.3 Global Polypeptide Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Polypeptide Vaccine Revenue by Type (2019-2030)
4.2.1 Global Polypeptide Vaccine Revenue by Type (2019-2024)
4.2.2 Global Polypeptide Vaccine Revenue by Type (2025-2030)
4.2.3 Global Polypeptide Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Polypeptide Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Polypeptide Vaccine Sales by Application (2019-2030)
5.1.1 Global Polypeptide Vaccine Sales by Application (2019-2024)
5.1.2 Global Polypeptide Vaccine Sales by Application (2025-2030)
5.1.3 Global Polypeptide Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Polypeptide Vaccine Revenue by Application (2019-2030)
5.2.1 Global Polypeptide Vaccine Revenue by Application (2019-2024)
5.2.2 Global Polypeptide Vaccine Revenue by Application (2025-2030)
5.2.3 Global Polypeptide Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Polypeptide Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AmbioPharm
6.1.1 AmbioPharm Company Information
6.1.2 AmbioPharm Description and Business Overview
6.1.3 AmbioPharm Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AmbioPharm Polypeptide Vaccine Product Portfolio
6.1.5 AmbioPharm Recent Developments/Updates
6.2 Almac
6.2.1 Almac Company Information
6.2.2 Almac Description and Business Overview
6.2.3 Almac Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Almac Polypeptide Vaccine Product Portfolio
6.2.5 Almac Recent Developments/Updates
6.3 ACT
6.3.1 ACT Company Information
6.3.2 ACT Description and Business Overview
6.3.3 ACT Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ACT Polypeptide Vaccine Product Portfolio
6.3.5 ACT Recent Developments/Updates
6.4 Ultimovacs
6.4.1 Ultimovacs Company Information
6.4.2 Ultimovacs Description and Business Overview
6.4.3 Ultimovacs Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ultimovacs Polypeptide Vaccine Product Portfolio
6.4.5 Ultimovacs Recent Developments/Updates
6.5 Marker Therapeutics, Inc.
6.5.1 Marker Therapeutics, Inc. Company Information
6.5.2 Marker Therapeutics, Inc. Description and Business Overview
6.5.3 Marker Therapeutics, Inc. Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Marker Therapeutics, Inc. Polypeptide Vaccine Product Portfolio
6.5.5 Marker Therapeutics, Inc. Recent Developments/Updates
6.6 Immatics
6.6.1 Immatics Company Information
6.6.2 Immatics Description and Business Overview
6.6.3 Immatics Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Immatics Polypeptide Vaccine Product Portfolio
6.6.5 Immatics Recent Developments/Updates
6.7 OncoPep
6.7.1 OncoPep Company Information
6.7.2 OncoPep Description and Business Overview
6.7.3 OncoPep Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 OncoPep Polypeptide Vaccine Product Portfolio
6.7.5 OncoPep Recent Developments/Updates
6.8 Anergis
6.8.1 Anergis Company Information
6.8.2 Anergis Description and Business Overview
6.8.3 Anergis Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Anergis Polypeptide Vaccine Product Portfolio
6.8.5 Anergis Recent Developments/Updates
6.9 Sellas Life Sciences
6.9.1 Sellas Life Sciences Company Information
6.9.2 Sellas Life Sciences Description and Business Overview
6.9.3 Sellas Life Sciences Polypeptide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sellas Life Sciences Polypeptide Vaccine Product Portfolio
6.9.5 Sellas Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polypeptide Vaccine Industry Chain Analysis
7.2 Polypeptide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polypeptide Vaccine Production Mode & Process
7.4 Polypeptide Vaccine Sales and Marketing
7.4.1 Polypeptide Vaccine Sales Channels
7.4.2 Polypeptide Vaccine Distributors
7.5 Polypeptide Vaccine Customers
8 Polypeptide Vaccine Market Dynamics
8.1 Polypeptide Vaccine Industry Trends
8.2 Polypeptide Vaccine Market Drivers
8.3 Polypeptide Vaccine Market Challenges
8.4 Polypeptide Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AmbioPharm
ALMAC
ACT
Ultimovacs
Immatics
Anergis
SELLAS Life Sciences
Marker Therapeutics, Inc.
OncoPep
List of Tables
 Table 1. Global Polypeptide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Polypeptide Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Polypeptide Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Polypeptide Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Polypeptide Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Polypeptide Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Polypeptide Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Polypeptide Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Polypeptide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Polypeptide Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Polypeptide Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Polypeptide Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Polypeptide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polypeptide Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Polypeptide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Polypeptide Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Polypeptide Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Polypeptide Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Polypeptide Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Polypeptide Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Polypeptide Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Polypeptide Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Polypeptide Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Polypeptide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Polypeptide Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Polypeptide Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Polypeptide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Polypeptide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Polypeptide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Polypeptide Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Polypeptide Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Polypeptide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Polypeptide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Polypeptide Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Polypeptide Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Polypeptide Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Polypeptide Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Polypeptide Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Polypeptide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Polypeptide Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Polypeptide Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Polypeptide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Polypeptide Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Polypeptide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Polypeptide Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Polypeptide Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Polypeptide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Polypeptide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Polypeptide Vaccine Sales (K Dose) by Type (2019-2024)
 Table 51. Global Polypeptide Vaccine Sales (K Dose) by Type (2025-2030)
 Table 52. Global Polypeptide Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Polypeptide Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Polypeptide Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Polypeptide Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Polypeptide Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Polypeptide Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Polypeptide Vaccine Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Polypeptide Vaccine Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Polypeptide Vaccine Sales (K Dose) by Application (2019-2024)
 Table 61. Global Polypeptide Vaccine Sales (K Dose) by Application (2025-2030)
 Table 62. Global Polypeptide Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Polypeptide Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Polypeptide Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Polypeptide Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Polypeptide Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Polypeptide Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Polypeptide Vaccine Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Polypeptide Vaccine Price (US$/Dose) by Application (2025-2030)
 Table 70. AmbioPharm Company Information
 Table 71. AmbioPharm Description and Business Overview
 Table 72. AmbioPharm Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. AmbioPharm Polypeptide Vaccine Product
 Table 74. AmbioPharm Recent Developments/Updates
 Table 75. Almac Company Information
 Table 76. Almac Description and Business Overview
 Table 77. Almac Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Almac Polypeptide Vaccine Product
 Table 79. Almac Recent Developments/Updates
 Table 80. ACT Company Information
 Table 81. ACT Description and Business Overview
 Table 82. ACT Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. ACT Polypeptide Vaccine Product
 Table 84. ACT Recent Developments/Updates
 Table 85. Ultimovacs Company Information
 Table 86. Ultimovacs Description and Business Overview
 Table 87. Ultimovacs Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Ultimovacs Polypeptide Vaccine Product
 Table 89. Ultimovacs Recent Developments/Updates
 Table 90. Marker Therapeutics, Inc. Company Information
 Table 91. Marker Therapeutics, Inc. Description and Business Overview
 Table 92. Marker Therapeutics, Inc. Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Marker Therapeutics, Inc. Polypeptide Vaccine Product
 Table 94. Marker Therapeutics, Inc. Recent Developments/Updates
 Table 95. Immatics Company Information
 Table 96. Immatics Description and Business Overview
 Table 97. Immatics Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Immatics Polypeptide Vaccine Product
 Table 99. Immatics Recent Developments/Updates
 Table 100. OncoPep Company Information
 Table 101. OncoPep Description and Business Overview
 Table 102. OncoPep Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. OncoPep Polypeptide Vaccine Product
 Table 104. OncoPep Recent Developments/Updates
 Table 105. Anergis Company Information
 Table 106. Anergis Description and Business Overview
 Table 107. Anergis Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Anergis Polypeptide Vaccine Product
 Table 109. Anergis Recent Developments/Updates
 Table 110. Sellas Life Sciences Company Information
 Table 111. Sellas Life Sciences Description and Business Overview
 Table 112. Sellas Life Sciences Polypeptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 113. Sellas Life Sciences Polypeptide Vaccine Product
 Table 114. Sellas Life Sciences Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Polypeptide Vaccine Distributors List
 Table 118. Polypeptide Vaccine Customers List
 Table 119. Polypeptide Vaccine Market Trends
 Table 120. Polypeptide Vaccine Market Drivers
 Table 121. Polypeptide Vaccine Market Challenges
 Table 122. Polypeptide Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Polypeptide Vaccine
 Figure 2. Global Polypeptide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Polypeptide Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Synthetic Polypeptide Vaccines Product Picture
 Figure 5. Recombinant Polypeptide Vaccine Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Polypeptide Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Polypeptide Vaccine Market Share by Application: 2023 & 2030
 Figure 9. Infectious Disease Prevention
 Figure 10. Cancer Immunotherapy
 Figure 11. Others
 Figure 12. Global Polypeptide Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Polypeptide Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Polypeptide Vaccine Sales (2019-2030) & (K Dose)
 Figure 15. Global Polypeptide Vaccine Average Price (US$/Dose) & (2019-2030)
 Figure 16. Polypeptide Vaccine Report Years Considered
 Figure 17. Polypeptide Vaccine Sales Share by Manufacturers in 2023
 Figure 18. Global Polypeptide Vaccine Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Polypeptide Vaccine Players: Market Share by Revenue in Polypeptide Vaccine in 2023
 Figure 20. Polypeptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Polypeptide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Polypeptide Vaccine Sales Market Share by Country (2019-2030)
 Figure 23. North America Polypeptide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 24. United States Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Polypeptide Vaccine Sales Market Share by Country (2019-2030)
 Figure 27. Europe Polypeptide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Polypeptide Vaccine Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Polypeptide Vaccine Revenue Market Share by Region (2019-2030)
 Figure 35. China Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Polypeptide Vaccine Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Polypeptide Vaccine Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Polypeptide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Polypeptide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Polypeptide Vaccine by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Polypeptide Vaccine by Type (2019-2030)
 Figure 54. Global Polypeptide Vaccine Price (US$/Dose) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Polypeptide Vaccine by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Polypeptide Vaccine by Application (2019-2030)
 Figure 57. Global Polypeptide Vaccine Price (US$/Dose) by Application (2019-2030)
 Figure 58. Polypeptide Vaccine Value Chain
 Figure 59. Polypeptide Vaccine Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Peptide Vaccine for Tumor Market Research Report 2024
Global Peptide Based Vaccines for Cancer Market Research Report 2025
Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Cancer Therapeutics Market Research Report 2024
Polypeptide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Synthetic Peptide Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Therapy Market Research Report 2025
Global Adjuvant Peptide Market Research Report 2024
Global Synthesis Polypeptide Drugs Market Insights Forecast to 2030
Global Recombinant Protein Peptide Drug Market Research Report 2024
Global Therapeutic Cancer Vaccines Market Research Report 2024
Global Gene Engineered Subunit Vaccine Market Research Report 2024
Global Oral Proteins and Peptides Market Research Report 2025
Global Peptide and Oligonucleotide Drugs Market Research Report 2024
Global Influenza Subunit Vaccine Market Research Report 2024
Global Chemosynthetic Polypeptide Drugs Market Research Report 2024
Global Polypeptide API Market Research Report 2024
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions